Back to top
more

U.S. Physical Therapy (USPH)

(Delayed Data from NYSE)

$100.61 USD

100.61
30,485

+0.23 (0.23%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $100.55 -0.06 (-0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Company Summary

U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.

General Information

US Physical Therapy, Inc

1300 WEST SAM HOUSTON PARKWAY SUITE 300

HOUSTON, TX 77042

Phone: 713-297-7000

Fax: 713-297-7090

Web: http://www.usph.com

Email: chendrickson@usph.com

Industry Medical - Outpatient and Home Healthcare
Sector Medical
Fiscal Year End December
Last Reported Quarter 3/31/2024
Earnings Date

This is a confirmed date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information.

 5/7/2024

EPS Information

Current Quarter EPS Consensus Estimate 0.58
Current Year EPS Consensus Estimate 2.77
Estimated Long-Term EPS Growth Rate 7.60
Earnings Date

This is a confirmed date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information.

 5/7/2024

Price and Volume Information

Zacks Rank Premium
Yesterday's Close 100.38
52 Week High 124.11
52 Week Low 78.08
Beta 1.39
20 Day Moving Average 73,982.25
Target Price Consensus 119.13

USPH

% Price Change
4 Week -10.86
12 Week 6.61
YTD 8.02
% Price Change Relative to S&P 500
4 Week -8.16
12 Week 3.66
YTD 1.83
Share Information
Shares Outstanding (millions) 15.07
Market Capitalization (millions) 1,516.00
Short Ratio NA
Last Split Date 6/29/2001
Dividend Information
Dividend Yield 1.75%
Annual Dividend $1.76
Payout Ratio 0.67
Change in Payout Ratio 0.23
Last Dividend Payout / Amount 3/11/2024 / $0.44

Fundamental Ratios

P/E
P/E (F1) 36.32
Trailing 12 Months 39.30
PEG Ratio 4.77
EPS Growth
vs. Previous Year 1.72%
vs. Previous Quarter -4.84%
   
Sales Growth
vs. Previous Year 9.65%
vs. Previous Quarter 3.20%
   
Price Ratios
Price/Book 3.16
Price/Cash Flow 21.58
Price / Sales 2.51
ROE
3/31/24 NA
12/31/23 8.52
9/30/23 9.03
ROA
3/31/24 NA
12/31/23 3.92
9/30/23 3.92
Current Ratio
3/31/24 NA
12/31/23 2.28
9/30/23 2.77
Quick Ratio
3/31/24 NA
12/31/23 2.28
9/30/23 2.77
Operating Margin
3/31/24 NA
12/31/23 6.27
9/30/23 6.19
Net Margin
3/31/24 NA
12/31/23 4.67
9/30/23 5.11
Pre-Tax Margin
3/31/24 NA
12/31/23 8.16
9/30/23 9.11
Book Value
3/31/24 NA
12/31/23 31.85
9/30/23 32.93
Inventory Turnover
3/31/24 NA
12/31/23 NA
9/30/23 NA
Debt-to-Equity
3/31/24 NA
12/31/23 0.29
9/30/23 0.29
Debt to Capital
3/31/24 NA
12/31/23 39.66
9/30/23 39.05